GABAPENTIN

Product NDC
43602-466
11-digit product format
436020466
Labeler code
43602
Product ID
43602-466_dc5d1f9f-b231-4320-aade-f051a8f4deed
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Gabapentin
Dosage form
TABLET
Route
ORAL
Labeler
Ascent Pharmaceuticals, Inc
Application
ANDA214957
Marketing category
ANDA
Marketing start
2021-10-01
Marketing end
0000-00-00
Substance
GABAPENTIN
Active strength
600 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
594e2c86-3079-4e6e-96c9-48f7a8afc78dProduct name120230718
a62a50ac-1535-4461-9768-8ae703e2e9fbProduct name120210525
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877Product name120140508
bc07ef78-e82d-0c19-31f4-31f263780582Product name120140508

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43602-466GABAPENTIN TABLET [ASCENT PHARMACEUTICALS, INC]3Legacy NDC20211008_11580370-55dd-4b61-b051-68b49f6fd2ea.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
43602-466-0543602046605500 TABLET in 1 BOTTLE (43602-466-05) 500 tablet2021-10-010000-00-00NoNoCurrent
43602-466-304360204663030 TABLET in 1 BOTTLE (43602-466-30) 30 tablet2021-10-010000-00-00NoNoCurrent